These findings integrate structural and molecular evidence into a unified pathogenic framework, highlighting the central role of ubiquitin dysregulation in the early initiation of airway fibrosis and providing new mechanistic insight that may inform future therapeutic strategies for BO. This evidence concerns the gene UBA52 and bronchiolitis obliterans syndrome.